Provided by Tiger Trade Technology Pte. Ltd.

Cibus Global Ltd.

1.88
-0.2500-11.74%
Post-market: 2.000.1200+6.38%19:59 EDT
Volume:1.91M
Turnover:3.42M
Market Cap:130.09M
PE:-0.68
High:2.14
Open:2.12
Low:1.65
Close:2.13
52wk High:4.19
52wk Low:1.09
Shares:69.20M
Float Shares:36.40M
Volume Ratio:1.97
T/O Rate:5.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7800
EPS(LYR):-2.7800
ROE:-220.96%
ROA:-12.87%
PB:5.96
PE(LYR):-0.68

Loading ...

Top Midday Decliners

MT Newswires Live
·
Mar 27

BUZZ-U.S. STOCKS ON THE MOVE-Corebridge, Robinhood, Navan

Reuters
·
Mar 26

Cibus prices follow-on offering of 6,976,744 Class A shares; gross proceeds rise to about $15 million

Reuters
·
Mar 26

Cibus, Inc. Announces Pricing of Public Offering of Class a Common Stock

THOMSON REUTERS
·
Mar 26

Cibus Inc - Offering Gross Proceeds About $15 Mln, or $17.2 Mln IF Option Exercised in Full

THOMSON REUTERS
·
Mar 26

Cibus Inc - Prices Public Offering of 7 Mln Shares at $2.15 per Share

THOMSON REUTERS
·
Mar 26

Cibus Plans Public Offering of Common Stock, Warrants; Shares Fall After Hours

MT Newswires Live
·
Mar 26

BUZZ-Agritech co Cibus tumbles after announcing stock offering

Reuters
·
Mar 26

Cibus announces Class A common stock offering, no amount given

TIPRANKS
·
Mar 26

BRIEF-Cibus, Inc. Announces Proposed Public Offering Of Class A Common Stock And Pre-Funded Warrants

Reuters
·
Mar 26

Cibus, Inc. Announces Proposed Public Offering of Class a Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Mar 26

Cibus Is Maintained at Hold by Jefferies

Dow Jones
·
Mar 26

Analysts Conflicted on These Healthcare Names: Cibus (CBUS), Arrowhead Pharmaceuticals (ARWR) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Mar 26

Cibus price target raised to $3 from $1.90 at Jefferies

TIPRANKS
·
Mar 26

Top Midday Decliners

MT Newswires Live
·
Mar 19

Cibus Sr VP Research Noel Sauer disposes of USD 2,428 of common shares

Reuters
·
Mar 18

Cibus Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 18

Agritech firm Cibus misses Q4 revenue estimates

Reuters
·
Mar 18

Cibus Q4 Adj. EPS $(0.42) Beats $(0.43) Estimate, Sales $1.057M Miss $1.644M Estimate. Adj. EPS excludes asset impairment charge of $0.17.

Benzinga
·
Mar 18

Cibus Q4 net loss rises 24% to USD 31.95 million on long-lived asset impairment of USD 9.12 million

Reuters
·
Mar 18